|
US2012076755A1
|
|
Hepatitis C virus inhibitors
|
|
US2012076756A1
|
|
Benzimidazole derivatives
|
|
US2011250172A1
|
|
Hepatitis C virus inhibitors
|
|
US2011142798A1
|
|
Hepatitis C virus inhibitors
|
|
US2011064695A1
|
|
Hepatitis C virus inhibitors
|
|
US2011070196A1
|
|
Hepatitis C virus inhibitors
|
|
US2011064697A1
|
|
Hepatitis C virus inhibitors
|
|
US2010233122A1
|
|
Benzimidazole derivatives
|
|
US2010226883A1
|
|
Linked diimidazole derivatives
|
|
US2010266543A1
|
|
Linked dibenzimidazole antivirals
|
|
US2010221215A1
|
|
Linked dibenzimidazole derivatives
|
|
US2009324544A1
|
|
Substituted cyclic pyrrolidine derivatives
|
|
US2009060874A1
|
|
Bicyclic pyrrolidine derivatives
|
|
US2009047247A1
|
|
Pyrrolidine Derivatives
|
|
US2009004140A1
|
|
4-substituted pyrrolidine as anti-infectives
|
|
US2008039406A1
|
|
3,6-bridged tylosin derivatives
|
